Cargando…
Involvement of Cox-2 in the metastatic potential of chemotherapy-resistant breast cancer cells
BACKGROUND: A major problem with the use of current chemotherapy regimens for several cancers, including breast cancer, is development of intrinsic or acquired drug resistance, which results in disease recurrence and metastasis. However, the mechanisms underlying this drug resistance are unknown. To...
Autores principales: | Kang, Ju-Hee, Song, Ki-Hoon, Jeong, Kyung-Chae, Kim, Sunshin, Choi, Changsun, Lee, Chang Hoon, Oh, Seung Hyun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3199868/ https://www.ncbi.nlm.nih.gov/pubmed/21813027 http://dx.doi.org/10.1186/1471-2407-11-334 |
Ejemplares similares
-
Systemic chemotherapy with doxorubicin, cisplatin and capecitabine for metastatic hepatocellular carcinoma
por: Park, Se Hoon, et al.
Publicado: (2006) -
The impact of microsatellite instability status and sidedness of the primary tumor on the effect of bevacizumab-containing chemotherapy in patients with metastatic colorectal cancer
por: Kim, Seung Tae, et al.
Publicado: (2018) -
Neuronal SphK1 acetylates COX2 and contributes to pathogenesis in a model of Alzheimer’s Disease
por: Lee, Ju Youn, et al.
Publicado: (2018) -
MYC amplification-conferred primary resistance to capmatinib in a MET-amplified NSCLC patient: a case report
por: Choi, Wonyoung, et al.
Publicado: (2022) -
Trastuzumab-associated autoimmune thyroid disease in a patient with metastatic breast cancer
por: Min, Hong Ki, et al.
Publicado: (2016)